PREVENTION OF CYCLOPHOSPHAMIDE CYSTITIS WITH 2-MERCAPTOETHANE SODIUM-SULFONATE - A HISTOLOGIC-STUDY

被引：30

作者：

FREEDMAN, A ^{[1
]}

EHRLICH, RM ^{[1
]}

LJUNG, BM ^{[1
]}

机构：

[1] UNIV CALIF LOS ANGELES,SCH MED,DEPT PATHOL,LOS ANGELES,CA 90024

来源：

JOURNAL OF UROLOGY | 1984年 / 132卷 / 03期

关键词：

D O I：

10.1016/S0022-5347(17)49751-5

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：580 / 582

页数：3

共 10 条

[1] ANTIDOTE AGAINST THE UROTOXIC SIDE-EFFECTS OF THE OXAZAPHOSPHORINE DERIVATES CYCLOPHOSPHAMIDE, IFOSFAMIDE AND TROFOSFAMIDE [J].

BROCK, N ;

STEKAR, J ;

POHL, J .

NATURWISSENSCHAFTEN, 1979, 66 (01) :60-61

[2]

BROCK N, 1979, ARZNEIMITTEL-FORSCH, V29-1, P659

[3] CYCLOPHOSPHAMIDE CYSTITIS - IDENTIFICATION OF ACROLEIN AS THE CAUSATIVE AGENT [J].

COX, PJ .

BIOCHEMICAL PHARMACOLOGY, 1979, 28 (13) :2045-2049

[4] INCIDENCE OF BLADDER-CANCER AFTER CYCLOPHOSPHAMIDE THERAPY [J].

FAIRCHILD, WV ;

SPENCE, CR ;

SOLOMON, HD ;

GANGAI, MP .

JOURNAL OF UROLOGY, 1979, 122 (02) :163-164

[5]

FORNI AM, 1964, CANCER, V17, P1348, DOI 10.1002/1097-0142(196410)17:10<1348::AID-CNCR2820171017>3.0.CO

[6]

2-0

[7]

KOSS LG, 1967, LAB INVEST, V16, P44

[8]

PHILIPS FREDERICK S., 1961, CANCER RES, V21, P1577

[9]

POHL J, 1982, TOXICOLOGY PHARMACOK

[10]

WALKER SE, 1971, J LAB CLIN MED, V78, P978

← 1 →